Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Jul 24, 2026, 4:00 PM EDT
1.261
-0.019 (-1.45%)
After-hours: Jul 24, 2026, 7:59 PM EDT

Daré Bioscience Revenue

Daré Bioscience had revenue of $152.46K in the quarter ending March 31, 2026, with 499.58% growth. This brings the company's revenue in the last twelve months to $1.16M, up 4,366.48% year-over-year. In the year 2025, Daré Bioscience had annual revenue of $1.03M with 10,429.36% growth.

Revenue (ttm)
$1.16M
Revenue Growth
+4,366.48%
P/S Ratio
16.57
Revenue / Employee
$48,218
Employees
24
Market Cap
19.17M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03M1.02M10,429.36%
Dec 31, 20249.78K-2.80M-99.65%
Dec 31, 20232.81M-7.19M-71.92%
Dec 31, 202210.00M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 201480.00K74.00K1,233.33%
Dec 31, 20136.00K-619.00K-99.04%
Dec 31, 2012625.00K619.00K10,316.67%
Dec 31, 20116.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Palatin Technologies12.88M
Lipocine2.00M
Longeveron1.22M
Werewolf Therapeutics1.14M
Pluri1.08M
Allarity Therapeutics345.00K
Lisata Therapeutics170.00K
Revenue Rankings

DARE News

More News